MCE 的所有產品僅用作科學研究或藥證申報，我們不為任何個人用途提供產品和服務。

YKL-05-099

產品活性：YKL-05-099 是一種鹽誘導型激酶 (SIK) 抑制劑。YKL-05-099 作用于SIK1 和 SIK3，IC₅₀ 分別約為 10 和 30 nM。YKL-05-099 抑制 SIK2 的活性稍低，IC₅₀ 值為 40 nM。

研究領域：Immunology/Inflammation

作用靶點：Salt-inducible Kinase (SIK)

In Vitro: YKL-05-099 has slightly less potent SIK2-inhibitory (IC₅₀=40 nM) and IL-10-enhancing activities (EC₅₀=460 nM). YKL-05-099 binds to SIK1 and SIK3 with IC₅₀s of 10 and 30 nM, respectively, in a competitive binding assay. Preincubating bone marrow-derived macrophages with YKL-05-099 reduces LPS stimulated phosphorylation of HDAC5 at the SIK-specific phosphorylation site Ser259. YKL-05-099 suppresses production of the inflammatory cytokines TNFα, IL-6 and IL-12p40, and only modestly enhances IL-1β release in BMDCs stimulated with the yeast cell wall extract Zymosan A.

In Vivo: YKL-05-099 is non-toxic at concentrations less than 10 μM and stable in mouse liver microsomes for more than 2 hours. YKL-05-099 is highly soluble (PBS solubility=428 μM) and present in an unbound state at appreciable levels in mouse plasma. YKL-05-099 dose dependently decreases phosphorylation of HDAC5 at the SIK-regulated site Ser259; reduced phosphorylation is observed at the lowest dose (5 mg/Kg) and is below the limit of detection by immunoblotting beginning at the 20 mg/Kg dose. YKL-05-099 dose-dependently reduces abundance of TNFα in serum beginning at 5 mg/Kg, and increases IL-10 levels at the 20 mg/Kg dose by more than 2-fold.

相關產品：Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Kinase Inhibitor Library  |  Pyroptosis Compound Library  |  Targeted Diversity Library  |  Heterocyclic Compound Library  |  ARN-3236  |  MR22  |  Phanginin A  |  HG-9-91-01  |  RSS0680  |  YKL-06-062  |  MRIA9  |  DB1113  |  Pterosin B  |  WH-4-025  |  DB0614  |  MRT199665  |  YKL-06-061  |  GLPG3970

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種*僅有化合物庫，我們致力于為*科研客戶提供前沿的高品質小分子活性化合物；
•   50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領；
•   產品種類涵蓋各種重組蛋白，多肽，常用試劑盒 ，更有 PROTAC、ADC 等特色產品，廣泛應用于新藥研發、生命科學等科研項目；
•   提供虛擬篩選，離子通道篩選，代謝組學分析檢測分析，藥物篩選等專業技術服務；
•   設有專業的實驗中心和嚴格的質控、驗證體系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質檢報告，確保產品的高純度、高品質；
•   產品的生物活性多經各國客戶實驗驗證；
•   Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果；
•   專業團隊跟蹤新的制藥及生命科學研究進展，為您提供*新的活性化合物；
•   與世界各大制藥公司及*科研機構建立了長期的合作。